HS-10182, an EGFR Tyrosine Kinase Inhibitor, Increases Radiation Sensitivity in Non-Small Cell Lung Cancer With EGFR T790M Mutation

被引：0
|
作者：
Wang, Y. [1 ]
Chen, Y. [1 ]
Liu, N. [2 ]
Zhao, L. [3 ]
机构：
[1] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
[2] Tianjin Med Univ, Canc Inst & Hosp, Dept Radiotherapy Oncol, Tianjin, Peoples R China
[3] Tianjin Med Univ, Canc Hosp & Inst, Tianjin, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1719
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3067
引用
收藏
页码：E433 / E433
页数：1
相关论文
共 50 条
  • [1] EGFR tyrosine kinase inhibitor HS-10182 increases radiation sensitivity in non-small cell lung cancers with EGFR T790M mutation
    Chen, Yang
    Wang, Youyou
    Zhao, Lujun
    Wang, Ping
    Sun, Jifeng
    Bao, Rudi
    Li, Chenghai
    Liu, Ningbo
    CANCER BIOLOGY & MEDICINE, 2018, 15 (01) : 39 - 51
  • [2] EGFR tyrosine kinase inhibitor HS-10182 increases radiation sensitivity in non-small cell lung cancers with EGFR T790M mutation
    Yang Chen
    Youyou Wang
    Lujun Zhao
    Ping Wang
    Jifeng Sun
    Rudi Bao
    Chenghai Li
    Ningbo Liu
    Cancer Biology & Medicine, 2018, (01) : 39 - 51
  • [3] EGFR tyrosine kinase inhibitor HS-10182 increases radiation sensitivity in non-small cell lung cancers with EGFR T790M mutation
    Yang Chen
    Youyou Wang
    Lujun Zhao
    Ping Wang
    Jifeng Sun
    Rudi Bao
    Chenghai Li
    Ningbo Liu
    Cancer Biology & Medicine, 2018, 15 (01) : 39 - 51
  • [4] Afatinib increases sensitivity to radiation in non-small cell lung cancer cells with acquired EGFR T790M mutation
    Zhang, Shirong
    Zheng, Xiaoliang
    Huang, Haixiu
    Wu, Kan
    Wang, Bing
    Chen, Xufeng
    Ma, Shenglin
    ONCOTARGET, 2015, 6 (08) : 5832 - 5845
  • [5] Effect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790M mutation of EGFR
    Hwang, Ki-Eun
    Kwon, Su-Jin
    Kim, Young-Suk
    Park, Do-Sim
    Kim, Byoung-Ryun
    Yoon, Kwon-Ha
    Jeong, Eun-Taik
    Kim, Hak-Ryul
    EXPERIMENTAL CELL RESEARCH, 2014, 323 (02) : 288 - 296
  • [6] REVERSAL OF RESISTANCE TO EGFR TYROSINE KINASE INHIBITOR BY EGFR T790M SPECIFIC SIRNA IN NON-SMALL CELL LUNG CANCER
    Lee, Choon-Taek
    Park, Mi-Young
    Eo, Eun Young
    Park, Jong Sun
    Cho, Young Jae
    Yoon, Ho-Il
    Lee, Jae Ho
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S458 - S458
  • [7] Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer
    Takeshi Masuda
    Satoru Miura
    Yuki Sato
    Motoko Tachihara
    Akihiro Bessho
    Atsushi Nakamura
    Taichi Miyawaki
    Kohei Yoshimine
    Masahide Mori
    Hideaki Shiraishi
    Kosuke Hamai
    Koji Haratani
    Sumiko Maeda
    Eriko Tabata
    Chiyoe Kitagawa
    Junko Tanizaki
    Takumi Imai
    Shohei Nogami
    Nobuyuki Yamamoto
    Kazuhiko Nakagawa
    Noboru Hattori
    Scientific Reports, 13
  • [8] Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer
    Masuda, Takeshi
    Miura, Satoru
    Sato, Yuki
    Tachihara, Motoko
    Bessho, Akihiro
    Nakamura, Atsushi
    Miyawaki, Taichi
    Yoshimine, Kohei
    Mori, Masahide
    Shiraishi, Hideaki
    Hamai, Kosuke
    Haratani, Koji
    Maeda, Sumiko
    Tabata, Eriko
    Kitagawa, Chiyoe
    Tanizaki, Junko
    Imai, Takumi
    Nogami, Shohei
    Yamamoto, Nobuyuki
    Nakagawa, Kazuhiko
    Hattori, Noboru
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [9] Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Hirano, Toshiyuki
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (01) : 31 - 38
  • [10] OSIMERTINIB, A THIRD-GENERATION TYROSINE KINASE INHIBITOR TARGETING NON-SMALL CELL LUNG CANCER WITH EGFR T790M MUTATIONS
    McCoach, C. E.
    Jimeno, A.
    DRUGS OF TODAY, 2016, 52 (10) : 561 - 568
12345